Bulgarian Movement Disorders and Multiple Sclerosis Society
The Bulgarian Movement Disorders and Multiple Sclerosis Society (MDMSS) is an organization which is the result of a merger between the two previously existing associations, the Movement Disorder Society and the Multiple Sclerosis Society. The Movement Disorder Society was found in 2003, and the Multiple Sclerosis Society in 2004. In 2003, they merged in one common association named Movement Disorders and Multiple Sclerosis Society (MDMSS), with principal place of business at Sv. Naum General Hospital for Active Treatment in Neurology and Psychiatry. The main priorities of the Society is to train neurologists and general practitioners in the issues of neurogenerative and demyelinating diseases, modern methods of treatment, ensuring Bulgarian and international experience in the management of movement disorder diseases. For the purposes of the Society, a website was created making available updated and useful information about the different groups of diseases, conditions and terms for membership in the Society, textbooks, series of monographs, consensuses, upcoming events in Bulgaria and abroad. All issues since 2004 of the main printed body, Movement Disorders Journal, are also published in the website. The website is addressed not only to professionals but also to patients. Here the patients can find the necessary information in simple language.

The Bulgarian Movement Disorders and Multiple Sclerosis Society (MDMSS) is an organization which is driven by scientific and practical objectives. One of its main objectives is to get more professionals to learn about the issues of movement disorder diseases and to establish a good connection between the outpatient and inpatient care. Our Society operates in close collaboration with the European Movement Disorders Society and we hope to have future joint projects. This partnership has to continue and we must expand the opportunities for specialization of our doctors in leading European centers. In order to achieve these objectives the management has set the following priority tasks:

1. Modernizing and maintaining the existing consulting rooms and centers for treatment of movement disorder diseases and multiple sclerosis.

2. Organizing the continuous training of neurologists in line with the European standards.

3. Organizing the training of general practitioners. They should understand well the issues of movement disorder diseases in order to refer such patients for a consultation with a neurologist, if needed.

4. Strengthening contacts with European and world movement disorder societies. Organizing mutual scientific events will allow us to know our colleagues from other countries and understand the European and world experience.

During our mandate, we hope to manage to enhance the role of the Society so that it becomes desired by each neurologist.

Acad. Ivan Milanov,